Evidence map›Paper›PMID 33142766›Full record

ArticleInternational journal of molecular sciences2020

18F-Fluorodeoxyglucose Positron Emission Tomography Tracks the Heterogeneous Brain Susceptibility to the Hyperglycemia-Related Redox Stress.

Alberto Miceli, Vanessa Cossu, Cecilia Marini, Patrizia Castellani, Stefano Raffa, Maria Isabella Donegani, Silvia Bruno, Silvia Ravera, Laura Emionite, Anna Maria Orengo and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. MutatedCells · 2022
    Article
  6. Effect of metformin onThe British journal of radiology · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Alberto MiceliDepartment of Health Sciences, University of Genoa, 16132 Genova, Italy.
Vanessa CossuDepartment of Health Sciences, University of Genoa, 16132 Genova, Italy.
Cecilia MariniNuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Patrizia CastellaniCell Biology, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Stefano RaffaDepartment of Health Sciences, University of Genoa, 16132 Genova, Italy.
Maria Isabella DoneganiDepartment of Health Sciences, University of Genoa, 16132 Genova, Italy.
Silvia BrunoDepartment of Experimental Medicine, Human Anatomy, University of Genoa, Genova 16132, Italy.
Silvia RaveraDepartment of Experimental Medicine, Human Anatomy, University of Genoa, Genova 16132, Italy.ORCID 0000-0002-0803-1042
Laura EmioniteAnimal Facility, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Anna Maria OrengoNuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Federica GrilloDepartment of Surgical Sciences and Integrated Diagnostics, Pathology Unit, University of Genoa, 16132 Genova, Italy.ORCID 0000-0001-6477-3182
Flavio NobiliDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Center of Excellence for Biomedical Research, University of Genoa, 16132 Genoa, Italy.ORCID 0000-0001-9811-0897
Silvia MorbelliDepartment of Health Sciences, University of Genoa, 16132 Genova, Italy.
Antonio UccelliDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Center of Excellence for Biomedical Research, University of Genoa, 16132 Genoa, Italy.
Gianmario SambucetiDepartment of Health Sciences, University of Genoa, 16132 Genova, Italy.ORCID 0000-0003-2979-6500
Matteo BaucknehtNuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.ORCID 0000-0002-1937-9116
Ospedale Policlinico San Martino · ITUniversity of Genoa · ITInstitute of Molecular Bioimaging and Physiology · IT

Funding

Associazione Italiana per la Ricerca sul Cancro IG 23201
6 · The paper itself

Abstract

In cognitively normal patients, mild hyperglycemia selectively decreases 18F-Fluorodeoxyglucose (FDG) uptake in the posterior brain, reproducing Alzheimer disease pattern, hampering the diagnostic accuracy of this widely used tool. This phenomenon might involve either a heterogeneous response of glucose metabolism or a different sensitivity to hyperglycemia-related redox stress. Indeed, previous studies reported a close link between FDG uptake and activation of a specific pentose phosphate pathway (PPP), triggered by hexose-6P-dehydrogenase (H6PD) and contributing to fuel NADPH-dependent antioxidant responses in the endoplasmic reticulum (ER). To clarify this issue, dynamic positron emission tomography was performed in 40 BALB/c mice four weeks after administration of saline (

Indexed as

GlycolysisAnimalsBiological TransportBrainDiabetes Mellitus, ExperimentalEndoplasmic ReticulumFluorodeoxyglucose F18HyperglycemiaMaleMiceMice, Inbred BALB COxidation-ReductionPentose Phosphate PathwayPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticalsbrain glucose metabolismFDG-PEThyperglycemiaoxidative stressreticular pentose phosphate pathway

Identifiers

PMID33142766
PMCPMC7672601
OpenAlexW3097890147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.